首页> 美国卫生研究院文献>other >Recent Controversies on Comparative Effectiveness Research Investigations: Challenges Opportunities and Pitfalls
【2h】

Recent Controversies on Comparative Effectiveness Research Investigations: Challenges Opportunities and Pitfalls

机译:比较有效性研究调查的最新争议:挑战机遇和陷阱

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of comparative effectiveness research (CER) is to improve health outcomes by developing and disseminating evidence-based information about which currently available interventions and practices are most effective for patients. While Randomized Controlled Trials (RCT) are the hallmark of scientific proof, when they have been used to compare interventions used in variable ways by different clinicians (Comparative Effectiveness RCTs, CER RCTs) they have at times, generated controversy. Usually the background for the CER RCT is a range of ‘standard therapy’ or ‘standard of care’. This may have been adopted on observational data alone, pilot data. At times, such prior data may derive from populations that differ from the population in which the widely variable standard approach is being applied. We believe controversies related to these CER-RCTs result from confusing ‘accepted’ therapies and ‘rigorously evaluated therapies”. We first define evidence based medicine, and consider how well neonatology conforms to that definition. We then contrast the approach of testing new therapies and those already existing and widely adopted, as in CER-RCTs. We next examine a central challenge in incorporating the control arm within CER, and aspects of the ‘titrated’ trial. We finally briefly consider some ethical issues that have arisen, and briefly discuss the wide range of neonatology practices that could be subject to CER-RCTs or alternative CER-based strategies that might inform practice in the absence of RCTs. Throughout, we emphasize the lack of awareness of the lay community, and indeed many researchers or commentators, in appreciating the wide variation of standard of care. There is a corresponding need to identify the best uses of available resources that will lead to the best outcomes for our patients. We conclude that CER is an essential methodology in modern neonatology to address many unanswered questions and test unproven therapies in newborn care.
机译:比较有效性研究(CER)的目的是通过开发和传播基于证据的信息来改善健康结果,这些信息是有关当前可用的干预措施和实践对患者最有效的。尽管随机对照试验(RCT)是科学证明的标志,但当它们被用来比较不同临床医生有时以不同方式(比较有效性RCT,CER RCT)使用的干预措施时,引起了争议。通常,CER RCT的背景是一系列“标准疗法”或“标准护理”。可能仅在观测数据,飞行员数据上采用了此方法。有时,这些先验数据可能来自与采用广泛可变的标准方法的人群不同的人群。我们认为,与这些CER-RCT相关的争议是由于混淆了“公认的”疗法和“经过严格评估的疗法”而引起的。我们首先定义基于证据的医学,然后考虑新生儿医学与该定义的符合程度。然后,我们对比了CER-RCT中测试新疗法以及已经存在并被广泛采用的疗法的方法。接下来,我们将探讨将控制机构纳入CER的主要挑战,以及“滴定”试验的各个方面。最后,我们简要地考虑已经出现的一些道德问题,并简要讨论可能受CER-RCT约束的广泛的新生儿医学实践或基于替代CER的策略,这些策略可能会在没有RCT的情况下为实践提供信息。在整个过程中,我们强调缺乏对非专业社区以及许多研究人员或评论员的认识,从而无法意识到护理标准的广泛差异。因此,有必要确定可用资源的最佳用途,以使我们的患者获得最佳结果。我们得出的结论是,CER是现代新生儿学中解决许多未解决的问题并测试未经证实的新生儿护理方法的基本方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号